Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP332581.RAMn5txAQ6YlyRH6vhv2U94-92GRixj1ShIlTr_cR_kOc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP332581.RAMn5txAQ6YlyRH6vhv2U94-92GRixj1ShIlTr_cR_kOc130_assertion type Assertion NP332581.RAMn5txAQ6YlyRH6vhv2U94-92GRixj1ShIlTr_cR_kOc130_head.
- NP332581.RAMn5txAQ6YlyRH6vhv2U94-92GRixj1ShIlTr_cR_kOc130_assertion description "[Selective VDR ligands, in particular, may offer additional benefits in the treatment of bone disease, and may potentially reduce adverse effects related to cardiovascular disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP332581.RAMn5txAQ6YlyRH6vhv2U94-92GRixj1ShIlTr_cR_kOc130_provenance.
- NP332581.RAMn5txAQ6YlyRH6vhv2U94-92GRixj1ShIlTr_cR_kOc130_assertion evidence source_evidence_literature NP332581.RAMn5txAQ6YlyRH6vhv2U94-92GRixj1ShIlTr_cR_kOc130_provenance.
- NP332581.RAMn5txAQ6YlyRH6vhv2U94-92GRixj1ShIlTr_cR_kOc130_assertion SIO_000772 18826852 NP332581.RAMn5txAQ6YlyRH6vhv2U94-92GRixj1ShIlTr_cR_kOc130_provenance.
- NP332581.RAMn5txAQ6YlyRH6vhv2U94-92GRixj1ShIlTr_cR_kOc130_assertion wasDerivedFrom befree-20140225 NP332581.RAMn5txAQ6YlyRH6vhv2U94-92GRixj1ShIlTr_cR_kOc130_provenance.
- NP332581.RAMn5txAQ6YlyRH6vhv2U94-92GRixj1ShIlTr_cR_kOc130_assertion wasGeneratedBy ECO_0000203 NP332581.RAMn5txAQ6YlyRH6vhv2U94-92GRixj1ShIlTr_cR_kOc130_provenance.